Cyclopenthiazide / Amiloride Hydrochloride

环戊噻嗪/盐酸阿米洛利

Report date: 2026/05/20 20:02:01

Base Information

Drug NameCyclopenthiazide / Amiloride Hydrochloride
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitorsSodium channel alpha subunit blockers
TargetsThiazide-sensitive sodium-chloride cotransporterSodium channel alpha subunit
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsYes CyclopenthiazideAmiloride Hydrochloride
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMercury Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMercury Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A